483 related articles for article (PubMed ID: 24987795)
1. Use of a synthetic cannabinoid in a correctional population for posttraumatic stress disorder-related insomnia and nightmares, chronic pain, harm reduction, and other indications: a retrospective evaluation.
Cameron C; Watson D; Robinson J
J Clin Psychopharmacol; 2014 Oct; 34(5):559-64. PubMed ID: 24987795
[TBL] [Abstract][Full Text] [Related]
2. The use of a synthetic cannabinoid in the management of treatment-resistant nightmares in posttraumatic stress disorder (PTSD).
Fraser GA
CNS Neurosci Ther; 2009; 15(1):84-8. PubMed ID: 19228182
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study.
Jetly R; Heber A; Fraser G; Boisvert D
Psychoneuroendocrinology; 2015 Jan; 51():585-8. PubMed ID: 25467221
[TBL] [Abstract][Full Text] [Related]
4. Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
Babson KA; Sottile J; Morabito D
Curr Psychiatry Rep; 2017 Apr; 19(4):23. PubMed ID: 28349316
[TBL] [Abstract][Full Text] [Related]
5. Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013.
Waltman SH; Shearer D; Moore BA
Curr Psychiatry Rep; 2018 Oct; 20(12):108. PubMed ID: 30306339
[TBL] [Abstract][Full Text] [Related]
6. Treating nightmares in posttraumatic stress disorder with dronabinol: study protocol of a multicenter randomized controlled study (THC PTSD-trial).
Roepke S; Schoofs N; Priebe K; Wülfing F; Schmahl C; Röhle R; Zähringer J; Lotter T; Otte C; Koglin S
BMC Psychiatry; 2023 May; 23(1):319. PubMed ID: 37147642
[TBL] [Abstract][Full Text] [Related]
7. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain: A systematic review of randomized controlled studies].
Petzke F; Enax-Krumova EK; Häuser W
Schmerz; 2016 Feb; 30(1):62-88. PubMed ID: 26830780
[TBL] [Abstract][Full Text] [Related]
9. Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence.
Nappi CM; Drummond SP; Hall JM
Neuropharmacology; 2012 Feb; 62(2):576-85. PubMed ID: 21396945
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy for sleep disturbances in post-traumatic stress disorder (PTSD): A network meta-analysis.
Lappas AS; Glarou E; Polyzopoulou ZA; Goss G; Huhn M; Samara MT; Christodoulou NG
Sleep Med; 2024 Jul; 119():467-479. PubMed ID: 38795401
[TBL] [Abstract][Full Text] [Related]
11. The abuse potential of the synthetic cannabinoid nabilone.
Ware MA; St Arnaud-Trempe E
Addiction; 2010 Mar; 105(3):494-503. PubMed ID: 20402993
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: an overview of the literature.
van Liempt S; Vermetten E; Geuze E; Westenberg H
Ann N Y Acad Sci; 2006 Jul; 1071():502-7. PubMed ID: 16891608
[TBL] [Abstract][Full Text] [Related]
13. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
Forsythe ML; Boileau AJ
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
[TBL] [Abstract][Full Text] [Related]
14. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
Lile JA; Kelly TH; Hays LR
Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
[TBL] [Abstract][Full Text] [Related]
15. Nabilone pharmacotherapy for cannabis dependence: A randomized, controlled pilot study.
Hill KP; Palastro MD; Gruber SA; Fitzmaurice GM; Greenfield SF; Lukas SE; Weiss RD
Am J Addict; 2017 Dec; 26(8):795-801. PubMed ID: 28921814
[TBL] [Abstract][Full Text] [Related]
16. Cognitive behavioral therapy for insomnia in posttraumatic stress disorder: a randomized controlled trial.
Talbot LS; Maguen S; Metzler TJ; Schmitz M; McCaslin SE; Richards A; Perlis ML; Posner DA; Weiss B; Ruoff L; Varbel J; Neylan TC
Sleep; 2014 Feb; 37(2):327-41. PubMed ID: 24497661
[TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review.
Hindocha C; Cousijn J; Rall M; Bloomfield MAP
J Dual Diagn; 2020; 16(1):120-139. PubMed ID: 31479625
[No Abstract] [Full Text] [Related]
18. The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial.
Ware MA; Fitzcharles MA; Joseph L; Shir Y
Anesth Analg; 2010 Feb; 110(2):604-10. PubMed ID: 20007734
[TBL] [Abstract][Full Text] [Related]
19. Nabilone for the Management of Pain.
Tsang CC; Giudice MG
Pharmacotherapy; 2016 Mar; 36(3):273-86. PubMed ID: 26923810
[TBL] [Abstract][Full Text] [Related]
20. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
Taylor HR; Freeman MK; Cates ME
Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
